Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation
Authors
Keywords
-
Journal
Journal of the American Heart Association
Volume 9, Issue 11, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-05-23
DOI
10.1161/jaha.119.015089
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence and determinants of Hyperpolypharmacy in adults with heart failure: an observational study from the National Health and Nutrition Examination Survey (NHANES)
- (2019) Peter J. Kennel et al. BMC Cardiovascular Disorders
- No decline in the risk of heart failure after incident atrial fibrillation: A community study assessing trends overall and by ejection fraction
- (2017) Alanna M. Chamberlain et al. HEART RHYTHM
- What is polypharmacy? A systematic review of definitions
- (2017) Nashwa Masnoon et al. BMC Geriatrics
- Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial
- (2016) Jeroen Jaspers Focks et al. BMJ-British Medical Journal
- Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial
- (2016) Jeroen Jaspers Focks et al. BMJ-British Medical Journal
- How to define valvular atrial fibrillation?
- (2015) Laurent Fauchier et al. Archives of Cardiovascular Diseases
- Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial FibrillationCLINICAL PERSPECTIVE
- (2015) Jonathan P. Piccini et al. CIRCULATION
- Five-Year Follow-Up After Catheter Ablation of Persistent Atrial Fibrillation Using the Stepwise Approach and Prognostic Factors for Success
- (2015) D. Schreiber et al. Circulation-Arrhythmia and Electrophysiology
- Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial
- (2015) Marco Proietti et al. Clinical Research in Cardiology
- Risk of stroke after catheter ablation versus cardioversion for atrial fibrillation: A propensity-matched study of 24,244 patients
- (2015) Peter A. Noseworthy et al. HEART RHYTHM
- Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
- (2015) Elizabeth D. Kantor et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Frailty and polypharmacy
- (2015) Y. Rolland et al. Journal of Nutrition Health & Aging
- Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people
- (2015) Marie Herr et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines
- (2015) S. Dumbreck et al. BMJ-British Medical Journal
- Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines
- (2015) S. Dumbreck et al. BMJ-British Medical Journal
- Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation
- (2015) Peter A. Noseworthy et al. Journal of the American Heart Association
- New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events
- (2015) Agon Mekaj et al. Therapeutics and Clinical Risk Management
- Polypharmacy is Associated with an Increased Risk of Bleeding in Elderly Patients with Venous Thromboembolism
- (2014) Waltraud Leiss et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations
- (2014) Dae Hyun Kim et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke
- (2013) J. P. Piccini et al. EUROPEAN HEART JOURNAL
- Defining and Measuring Chronic Conditions: Imperatives for Research, Policy, Program, and Practice
- (2013) Richard A. Goodman et al. Preventing Chronic Disease
- Health Outcomes With Catheter Ablation or Antiarrhythmic Drug Therapy in Atrial Fibrillation
- (2012) Matthew R. Reynolds et al.
- Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
- (2012) Danijela Gnjidic et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data
- (2012) Susan E. Andrade et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A systematic review of validated methods for identifying heart failure using administrative data
- (2012) Jane S. Saczynski et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- An automated database case definition for serious bleeding related to oral anticoagulant use
- (2011) Andrew Cunningham et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now